Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Resistance Oncology ApS
APS
Active
Advertising protection
CVR 36945125
Amaliegade 13, 1256
København K
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2015 · 10 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Resistance Oncology ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
NA
Nils Aage Brünner
Management
Management
2022
KP
Kasper Pasternak Jørgensen
Management
Management
2022
Former (3)
JP
Jørgen Peter Jørgensen
Management
Management
2016 – 2022
PA
Peter Andreas Stakemann
Chief Executive Officer
Chief Executive Officer
2015 – 2015
MF
Morten Fadum Nissen
Management
Management
2015 – 2016
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Pasternak Holding ApS
Company
50–66.65%
50–66.65%
2026
TIMPCO NB ApS
Company
25–33.32%
25–33.32%
2025
Alexander Meier Holding ApS
Company
5–9.99%
5–9.99%
2025
CORTRIS ApS
Company
100%
100%
2015
PASTERNAK JØRGENSEN HOLDING ApS
Company
50–66.65%
50–66.65%
2025
Kristian Arp Regnersgaard
Individual
5–9.99%
5–9.99%
2015
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Resistance Oncology ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network